Extensive Nobel Prize–recognized research has shown that cells and microorganisms
within the human body generate gaseous signaling molecules, such as nitric oxide (NO),
which are essential regulators of physiological and pathological processes.Leveraging this scientific insight,
Sunvou has pioneered breath-based detection technologies for NO and other gaseous biomarkers,
leading the emergence of a new sector in medical and healthcare diagnostics.
Product Portfolio
Respiratory Product Line
Hospital
Nacoulon® Breath Analyzer Series CA & DA
Combined Multimolecular, Multisite, Multiparameter Breath Testing for Comorbidities (e.g., Respiratory & Digestive Conditions) and Critical Illnesses
CA Series – Inflammatory Subtyping Combined Breath Tests
- Nitric Oxide (NO, standard) + Carbon Monoxide (CO) & Hydrogen Sulfide (H₂S, optional); combined testing for Type 2 and non-Type 2 inflammatory subtypes.
- Combined testing for inflammation localization (large airways + upper & small airways) and systemic inflammation.
- Online mode (standard) + offline & tidal breathing modes (optional); suitable for all populations.
- Exhaled breath quality control + standard gas & self-calibration quality control; comprehensive quality assurance.
- Applicable Departments: Respiratory Medicine, Pediatrics, Rhinology, Surgery, Radiology, Physical Examination Center, etc.
- Indicated Conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD), interstitial lung disease, lung cancer, chronic cough, allergic rhinitis, sinusitis, nasal polyps, radiation pneumonitis, perioperative pulmonary complications, etc.
CA Series – Combined Breath Tests for Inflammation & Microbiota
- CA3478: Standard parameters (NO + H₂ + CO₂) – Combined Breath Test for Inflammation & Microbiota
- CA3138: Standard parameters (NO + H₂S + CO₂) – Combined Breath Test for Inflammation & Microbiota (supports oral sampling)
- CA4458: Standard parameters (NO + H₂ + CH₄ + CO₂ + O₂) – Combined Breath Test for Inflammation & Microbiota
- Applicable Departments: Respiratory Medicine, Pediatrics, Rhinology, Allergy & Immunology, Gastroenterology, Stomatology, Physical Examination Center, etc.
- Indicated Conditions: Allergic rhinitis, asthma, etc.; irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), colorectal cancer, etc.; microbiota imbalance-related inflammatory diseases involving the gut-lung, gut-heart, gut-liver, and gut-brain axes.
DA Series – Multimolecular, Multiparameter Combined Tests for Inflammation & Inflammatory Microbiota
Indicated Conditions: Allergic rhinitis, asthma, etc.; irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), colorectal cancer, etc.; microbiota imbalance-related inflammatory diseases involving the gut-lung, gut-heart, gut-liver, and gut-brain axes.
DA2123: Single-breath, variable-flow multiparameter testing (CaNO + CawNO + DawNO + JawNO)
DA7349: Multimolecular combined breath test for inflammation & microbiota (NO + H₂S + H₂ + CH₄ + CO + CO₂ + O₂) with AI olfactory diagnosis
Applicable Departments: High-end configuration for academic research and clinical services in departments related to Respiratory Medicine, Gastroenterology, Allergy, and Immunology, etc.
Primary Care
Inflammation Care® Breath Analyzer Series TM
Exquisitely designed for clinics, pharmacies, physical examination centers, elderly care facilities, communities, and more
- The gas detection technology shares the same origin as hospitals, and the diagnosis & treatment services are interconnected with hospitals.
- Hierarchical diagnosis and treatment for chronic respiratory diseases; cardiopulmonary health screening and physical examination.
- Hierarchical diagnosis and treatment for chronic respiratory diseases; cardiopulmonary health screening and physical examination.
• Optimal selection, increase or decrease of medications to improve treatment compliance.
• Reduction of acute exacerbations, emergency hospitalizations, and lung cancer risk.
- Combined testing of FeNO/CaNO/FeCO/FnNO for populations susceptible to allergies and sensitivities:
• Risk early warning and guidance for prevention and treatment.
• Reduction of the risk of asthma, chronic obstructive pulmonary disease (COPD), and lung cancer.
Hierarchical Healthcare Services – A great project for convenience & revenue!
Less trips to crowded hospitals – Save worry, money & time!
Respiratory Product Line
Home
Inflammation Care® Breath Analyzer Series HA & NA
Tailored for chronic respiratory patients and allergy-prone populations
- Equipped with an APP and Detection, Diagnosis & Treatment Service Cards
- The gas detection technology shares the same origin as hospitals, and the diagnosis & treatment services are interconnected with hospitals.
- Self-testing of FeNO/FnNO for patients with chronic cough and wheezing diseases
• Reducing acute exacerbations and emergency hospitalizations
- Self-testing of FeNO/FnNO for allergy-susceptible populations
• Reducing the risk of disease onset and progression to chronic conditions
One device, benefits for the whole family!
Fewer hospital trips, save worry, money and time!
Digestive Product Line
Nakoulon® DA7349 Series Breath Analyzer
Indications: Irritable Bowel Syndrome, Inflammatory Bowel Disease, Colorectal Cancer, Helicobacter Pylori Infection, Functional Dyspepsia, Liver Diseases, Allergic Rhinitis/ Asthma, and more
NO + H₂S + H₂ + CH₄ + CO + CO₂ + O₂
Multi-molecule gut inflammation and microbiome breath test, Olfactory AI and Multimodal Diagnosis
Departments served: Gastroenterology, Pediatrics, Health Checkups, Allergy & Immunology, and more—highly equipped.
Expert Consensus
500+
Brand Promotion
30000+
Clinical trials
400+
Scientific Evidence
40+